Proximal tubule sphingosine kinase-1 has a critical role in A 1 adenosine receptor-mediated renal protection from ischemia

Kidney International

Volumn 82, Issue 8, 2012, Pages 878-891

  Park, Sang W ^a   Kim, Mihwa ^a   Kim, Joo Y ^a   Brown, Kevin M ^a   Haase, Volker H ^b   D'Agati, Vivette D ^a   Thomas Lee, H ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LIFICIGUAT; RECEPTOR BLOCKING AGENT; SMALL INTERFERING RNA; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSINE KINASE 1; UNCLASSIFIED DRUG; W 146;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CELL DEATH; CELL NUCLEUS; CELL PROTECTION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG TARGETING; GENE FUNCTION; GENE INDUCTION; GENE LOCATION; GENE SILENCING; GENE SYNTHESIS; IN VIVO STUDY; KIDNEY ISCHEMIA; KIDNEY PROXIMAL TUBULE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RENAL PROTECTION; RNA INTERFERENCE;

EID: 84867081700     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2012.224     Document Type: Article

References (69)

1. Ikeda M, Prachasilchai W, Burne-Taney MJ et al. Ischemic acute tubular necrosis models and drug discovery: a focus on cellular inflammation. Drug Discov Today 2006; 11: 364-370.
2. Jones DR, Lee HT. Perioperative renal protection. Best Pract Res Clin Anaesthesiol 2008; 22: 193-208.
3. Jo SK, Rosner MH, Okusa MD. Pharmacologic treatment of acute kidney injury: why drugs haven't worked and what is on the horizon. Clin J Am Soc Nephrol 2007; 2: 356-365.
4. Jones DR, Lee HT. Protecting the kidney during critical illness. Curr Opin Anaesthesiol 2007; 20: 106-112.
5. Aronson S, Blumenthal R. Perioperative renal dysfunction and cardiovascular anesthesia: concerns and controversies. J Cardiothorac Vasc Anesth 1998; 17: 117-130.
6. Star RA. Treatment of acute renal failure. Kidney Int 1998; 54: 1817-1831.
7. Lee HT, Emala CW. Adenosine attenuates oxidant injury in human kidney proximal tubular cells via A1 and A2a adenosine receptor activation. Am J Physiol Renal Physiol 2002; 282: F844-F852.
8. Lee HT, Emala CW. Preconditioning and adenosine protect human proximal tubule cells in an in vitro model of ischemic injury. J Am Soc Nephrol 2002; 13: 2753-2761.
9. Lee HT, Gallos G, Nasr SH, Emala CW. A1 adenosine receptor activation inhibits inflammation, necrosis, and apoptosis after renal ischemiareperfusion injury in mice. J Am Soc Nephrol 2004; 15: 102-111.
10. Lee HT, Emala CW. Protective effects of renal ischemic preconditioning and adenosine pretreatment: role of A(1) and A(3) receptors. Am J Physiol Renal Physiol 2000; 278: F380-F387.
11. Lee HT, Xu H, Nasr SH et al. A1 adenosine receptor knockout mice exhibit increased renal injury following ischemia and reperfusion. Am J Physiol Renal Physiol 2004; 286: F298-F306.
12. Allende ML, Yamashita T, Proia RL. G-protein-coupled receptor S1P1 acts within endothelial cells to regulate vascular maturation. Blood 2003; 102: 3665-3667.
13. Matloubian M, Lo CG, Cinamon G et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 2004; 427: 355-360.
14. Chun J, Hla T, Lynch KR et al. International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature. Pharmacol Rev 2010; 62: 579-587.
15. Kim M, Kim M, Kim N et al. Isoflurane mediates protection from renal ischemia-reperfusion injury via sphingosine kinase and sphingosine-1-phosphate- dependent pathways. Am J Physiol Renal Physiol 2007; 293: F1827-F1835.
16. Kim M, Kim M, Park SW et al. Isoflurane protects human kidney proximal tubule cells against necrosis via sphingosine kinase and sphingosine-1-phosphate generation. Am J Nephrol 2010; 31: 353-362.
17. Park SW, Kim M, Kim M et al. Sphingosine kinase 1 protects against renal ischemia-reperfusion injury in mice via S1P1 receptor activation. Kidney Int 2011; 80: 1315-1327.
18. Karliner JS. Mechanisms of cardioprotection by lysophospholipids. J Cell Biochem 2004; 92: 1095-1103.
19. Vessey DA, Kelley M, Li L et al. Role of sphingosine kinase activity in protection of heart against ischemia reperfusion injury. Med Sci Monit 2006; 12: BR318-BR324.
20. Lien YH, Yong KC, Cho C et al. S1P(1)-selective agonist, SEW2871, ameliorates ischemic acute renal failure. Kidney Int 2006; 69: 1601-1608.
21. Allende ML, Dreier JL, Mandala S, Proia RL. Expression of the sphingosine 1-phosphate receptor, S1P1, on T-cells controls thymic emigration. J Biol Chem 2004; 279: 15396-15401.
22. Sanna MG, Liao J, Jo E et al. Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate. J Biol Chem 2004; 279: 13839-13848.
23. Bajwa A, Jo SK, Ye H et al. Activation of sphingosine-1-phosphate 1 receptor in the proximal tubule protects against ischemia-reperfusion injury. J Am Soc Nephrol 2010; 21: 955-965.
24. Rankin EB, Tomaszewski JE, Haase VH. Renal cyst development in mice with conditional inactivation of the von Hippel-Lindau tumor suppressor. Cancer Res 2006; 66: 2576-2583.
25. Vessey DA, Kelley M, Karliner JS. A rapid radioassay for sphingosine kinase. Anal Biochem 2005; 337: 136-142.
26. Kim M, Chen SW, Park SW et al. Kidney-specific reconstitution of the A1 adenosine receptor in A1 adenosine receptor knockout mice reduces renal ischemia-reperfusion injury. Kidney Int 2009; 75: 809-823.
27. Jablonski P, Howden BO, Rae DA et al. An experimental model for assessment of renal recovery from warm ischemia. Transplantation 1983; 35: 198-204.
28. Vinay P, Gougoux A, Lemieux G. Isolation of a pure suspension of rat proximal tubules. Am J Physiol 1981; 241: F403-F411.
29. Mitra P, Oskeritzian CA, Payne SG et al. Role of ABCC1 in export of sphingosine-1-phosphate from mast cells. Proc Natl Acad Sci USA 2006; 103: 16394-16399.
30. Nieuwenhuis B, Luth A, Chun J et al. Involvement of the ABC-transporter ABCC1 and the sphingosine 1-phosphate receptor subtype S1P(3) in the cytoprotection of human fibroblasts by the glucocorticoid dexamethasone. J Mol Med (Berl) 2009; 87: 645-657.
31. Lee YM, Venkataraman K, Hwang SI et al. A novel method to quantify sphingosine 1-phosphate by immobilized metal affinity chromatography (IMAC). Prostaglandins Other Lipid Mediat 2007; 84: 154-162.
32. Dallas S, Zhu X, Baruchel S et al. Functional expression of the multidrug resistance protein 1 in microglia. J Pharmacol Exp Ther 2003; 307: 282-290.
33. Prechtl S, Roellinghoff M, Scheper R et al. The multidrug resistance protein 1: a functionally important activation marker for murine Th1 cells. J Immunol 2000; 164: 754-761.
34. Schwalm S, Doll F, Romer I et al. Sphingosine kinase-1 is a hypoxiaregulated gene that stimulates migration of human endothelial cells. Biochem Biophys Res Commun 2008; 368: 1020-1025.
35. Faubel S. Acute kidney injury and multiple organ dysfunction sindrome. Minerva Urol Nefrol 2009; 61: 171-188.
36. Bonventre JV, Weinberg JM. Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 2003; 14: 2199-2210.
37. Vallon V, Osswald H. Adenosine receptors and the kidney. Handb Exp Pharmacol 2009: 443-470.
38. Okusa MD, Linden J, Macdonald T, Huang L. Selective A2A adenosine receptor activation reduces ischemia-reperfusion injury in rat kidney. Am J Physiol 1999; 277: F404-F412.
39. Grenz A, Osswald H, Eckle T et al. The reno-vascular A2B adenosine receptor protects the kidney from ischemia. PLoS Med 2008; 5: e137.
40. Joo JD, Kim M, Horst P et al. Acute and delayed renal protection against renal ischemia and reperfusion injury with A1 adenosine receptors. Am J Physiol Renal Physiol 2007; 293: F1847-F1857.
41. Hait NC, Oskeritzian CA, Paugh SW et al. Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases. Biochim Biophys Acta 2006; 1758: 2016-2026.
42. Liu H, Chakravarty D, Maceyka M et al. Sphingosine kinases: a novel family of lipid kinases. Prog Nucleic Acid Res Mol Biol 2002; 71: 493-511.
43. Maceyka M, Payne SG, Milstien S, Spiegel S. Sphingosine kinase, sphingosine-1-phosphate, and apoptosis. Biochim Biophys Acta 2002; 1585: 193-201.
44. Goparaju SK, Jolly PS, Watterson KR et al. The S1P2 receptor negatively regulates platelet-derived growth factor-induced motility and proliferation. Mol Cell Biol 2005; 25: 4237-4249.
45. Wadgaonkar R, Patel V, Grinkina N et al. Differential regulation of sphingosine kinases 1 and 2 in lung injury. Am J Physiol Lung Cell Mol Physiol 2009; 296: L603-L613.
46. Jo SK, Bajwa A, Ye H et al. Divergent roles of sphingosine kinases in kidney ischemia-reperfusion injury. Kidney Int 2009; 75: 167-175.
47. Venkataraman K, Thangada S, Michaud J et al. Extracellular export of sphingosine kinase-1a contributes to the vascular S1P gradient. Biochem J 2006; 397: 461-471.
48. Chae SS, Proia RL, Hla T. Constitutive expression of the S1P1 receptor in adult tissues. Prostaglandins Other Lipid Mediat 2004; 73: 141-150.
49. Jo SK, Bajwa A, Awad AS et al. Sphingosine-1-phosphate receptors: biology and therapeutic potential in kidney disease. Kidney Int 2008; 73: 1220-1230.
50. Young N, Van Jr B. Signal transduction of sphingosine-1-phosphate G protein-coupled receptors. Scientific World J 2006; 6: 946-966.
51. Awad AS, Ye H, Huang L et al. Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidney. Am J Physiol Renal Physiol 2006; 290: F1516-F1524.
52. Molitoris BA, Dahl R, Geerdes A. Cytoskeleton disruption and apical redistribution of proximal tubule Na(+)-K(+)-ATPase during ischemia. Am J Physiol 1992; 263: F488-F495.
53. Zheng DM, Kitamura T, Ikejima K et al. Sphingosine 1-phosphate protects rat liver sinusoidal endothelial cells from ethanol-induced apoptosis: role of intracellular calcium and nitric oxide. Hepatology 2006; 44: 1278-1287.
54. gudo-Lopez A, Miguel BG, Fernandez I et al. Involvement of mitochondria on neuroprotective effect of sphingosine-1-phosphate in cell death in an in vitro model of brain ischemia. Neurosci Lett 2010; 470: 130-133.
55. Kozawa O, Niwa M, Matsuno H et al. Sphingosine 1-phosphate induces heat shock protein 27 via p38 mitogen-activated protein kinase activation in osteoblasts. J Bone Miner Res 1999; 14: 1761-1767.
56. Takai S, Tokuda H, Matsushima-Nishiwaki R et al. Phosphatidylinositol 3-kinase/Akt plays a role in sphingosine 1-phosphate-stimulated HSP27 induction in osteoblasts. J Cell Biochem 2006; 98: 1249-1256.
57. Lee HT, Kim M, Jan M et al. Renal tubule necrosis and apoptosis modulation by A1 adenosine receptor expression. Kidney Int 2007; 71: 1249-1261.
58. Kim M, Park SW, Kim M et al. Selective renal over-expression of human heat shock protein 27 reduces renal ischemia-reperfusion injury in mice. Am J Physiol Renal Physiol 2010.
59. Schodel J, Klanke B, Weidemann A et al. HIF-prolyl hydroxylases in the rat kidney: physiologic expression patterns and regulation in acute kidney injury. Am J Pathol 2009; 174: 1663-1674.
60. Rosenberger C, Rosen S, Shina A et al. Activation of hypoxia-inducible factors ameliorates hypoxic distal tubular injury in the isolated perfused rat kidney. Nephrol Dial Transplant 2008; 23: 3472-3478.
61. Mooberry SL. Mechanism of action of 2-methoxyestradiol: new developments. Drug Resist Updat 2003; 6: 355-361.
62. Yeo EJ, Chun YS, Cho YS et al. YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1. J Natl Cancer Inst 2003; 95: 516-525.
63. Mansoor M, Melendez AJ. Recent trials for FTY720 (fingolimod): a new generation of immunomodulators structurally similar to sphingosine. Rev Recent Clin Trials 2008; 3: 62-69.
64. Park SW, Kim M, Chen SW et al. Sphinganine-1-phosphate protects kidney and liver after hepatic ischemia and reperfusion in mice through S1P(1) receptor activation. Lab Invest 2010; 90: 1209-1224.
65. Nakamura A, Imaizumi A, Yanagawa Y et al. Beta(2)-Adrenoceptor activation attenuates endotoxin-induced acute renal failure. J Am Soc Nephrol 2004; 15: 316-325.
66. Muzumdar MD, Tasic B, Miyamichi K et al. A global double-fluorescent Cre reporter mouse. Genesis 2007; 45: 593-605.
67. Slot C. Plasma creatinine determination. A new and specific Jaffe reaction method. Scand J Clin Lab Invest 1965; 17: 381-387.
68. Park SW, Kim M, Chen SW et al. Sphinganine-1-phosphate attenuates both hepatic and renal injury induced by hepatic ischemia and reperfusion in mice. Shock 2010; 33: 31-42.
69. Chen SW, Kim M, Kim M et al. Mice that overexpress human heat shock protein 27 have increased renal injury following ischemia reperfusion. Kidney Int 2008.